| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Increased levels of interleukin-10 and transforming growth factor-@b in theplasma and ascitic fluid of patients with advanced ovarian cancer |
Santin, A.D.;Bellone, S.;Ravaggi, A.;Roman, J.;Smith, C.V.;Pecorelli, S.;Cannon, M.J.;Parham, G.P.; |
British Journal of Obstetrics and Gynaecology |
2000-08-01 |
查看 |
| In vitro induction of tumor-specific human lymphocyte antigen classI-restricted CD8^+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsedautologous dendritic cells from patients with advanced ovarian cancer |
Santin, A.D.;Hermonat, P.L.;Ravaggi, A.;Bellone, S.;Pecorelli, S.;Cannon, M.J.;Parham, G.P.; |
American Journal of Obstetrics and Gynecology |
2000-09-01 |
查看 |
| In vitro induction of tumor-specific human lymphocyte antigen classI-restricted CD8^+ cytotoxic T lymphocytes by ovarian tumor antigen-pulsedautologous dendritic cells from patients with advanced ovarian cancer |
Santin, A.D.;Hermonat, P.L.;Ravaggi, A.;Bellone, S.;Pecorelli, S.;Cannon, M.J.;Parham, G.P.; |
American Journal of Obstetrics and Gynecology |
2000-09-01 |
查看 |
| Induction of ovarian tumor-specific CD8+ cytotoxic T lymphocytes byacid-eluted peptide-pulsed autologous dendritic cells |
Santin, A.D.;Bellone, S.;Ravaggi, A.;Pecorelli, S.;Cannon, M.J.;Parham, G.P.; |
Obstetrics and Gynecology |
2000-08-23 |
查看 |
| Increased levels of interleukin-10 and transforming growth factor-@b in theplasma and ascitic fluid of patients with advanced ovarian cancer |
Santin, A.D.;Bellone, S.;Ravaggi, A.;Roman, J.;Smith, C.V.;Pecorelli, S.;Cannon, M.J.;Parham, G.P.; |
British Journal of Obstetrics and Gynaecology |
2001-08-01 |
查看 |
| The novel serine protease tumor-associated differentially expressed gene-14(KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer |
Cane', S.;Bignotti, E.;Bellone, S.;Palmieri, M.;Casas, L.D.L.;Roman, J.J.;Pecorelli, S.;Cannon, M.J.;O'Brien, T.;Santin, A.D.; |
American Journal of Obstetrics and Gynecology |
2004-01-01 |
查看 |
| Racial differences in the overexpression of epidermal growth factor type IIreceptor (HER2/neu): A major prognostic indicator in uterine serouspapillary cancer |
Santin, A.D.;Bellone, S.;Siegel, E.R.;Palmieri, M.;Thomas, M.;Cannon, M.J.;Kay, H.H.;Roman, J.J.;Burnett, A.;Pecorelli, S.; |
American Journal of Obstetrics and Gynecology |
2005-03-01 |
查看 |
| Overexpression of kallikrein 10 (hK10) in uterine serous papillarycarcinomas |
Santin, A.D.;Diamandis, E.P.;Bellone, S.;Marizzoni, M.;Bandiera, E.;Palmieri, M.;Papasakelariou, C.;Katsaros, D.;Burnett, A.;Pecorelli, S.; |
American Journal of Obstetrics and Gynecology |
2006-05-01 |
查看 |
| Trastuzumab treatment in patients with advanced or recurrentendometrial carcinoma overexpressing HER2/neu |
Santin, A.D.;Bellone, S.;Roman, J.J.;McKenney, J.K.;Pecorelli, S.; |
International Journal of Gynecology & Obstetrics |
2008-08-01 |
查看 |
|
|
